Expression of β-catenin and AXIN2 in ameloblastomas
- PMID: 24596510
- PMCID: PMC3934066
- DOI: 10.5114/wo.2013.35278
Expression of β-catenin and AXIN2 in ameloblastomas
Abstract
Aim of the study: To investigate the expression status and association of β-catenin and AXIN2 in ameloblastoma.
Material and methods: 30 ameloblastoma specimens and 10 normal oral mucosa tissues were enrolled in the study. The protein and RNA levels of β-catenin and AXIN2 were detected by immunohistochemistry staining, Western blot, and real-time PCR analysis. The relationship between β-catenin and AXIN2 protein and clinico-pathological parameters and prognosis was subsequently determined.
Results: The results show that β-catenin mRNA expression was 1.24-fold higher in ameloblastomas than that in normal mucosa tissues, but AXIN2 mRNA expression was 0.47-fold lower in ameloblastomas than that in normal mucosa tissues (p < 0.05). The Western blot results show that β-catenin and AXIN2 protein in ameloblastomas had a significantly higher level than normal mucosa tissues (p < 0.05). Immunohistochemical staining of β-catenin and AXIN2 protein in ameloblastoma was expressed at a higher level than normal oral mucosa (p < 0.05).
Conclusions: AXIN2 and β-catenin play an important role in the tumorigenesis and progression of ameloblastoma.
Keywords: AXIN2; Wnt pathway; ameloblastoma; β-catenin.
Figures
References
-
- Luo HY, Li TJ. Odontogenic tumors: a study of 1309 cases in a Chinese population. Oral Oncol. 2009;45:706–11. - PubMed
-
- Adekeye EO, Lavery KM. Recurrent ameloblastoma of the maxillo-facial region. Clinical features and treatment. J Maxillofac Surg. 1986;14:153–7. - PubMed
-
- Ghandhi D, Ayoub AF, Pogrel MA, MacDonald G, Brocklebank LM, Moos KF. Ameloblastoma: a surgeon's dilemma. J Oral Maxillofac Surg. 2006;64:1010–4. - PubMed
-
- Carlson ER, Marx RE. The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg. 2006;64:484–94. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources